{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:46:27Z","timestamp":1760885187535},"reference-count":41,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,6,20]],"date-time":"2002-06-20T00:00:00Z","timestamp":1024531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Pediatr. Oncol."],"published-print":{"date-parts":[[2002,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Longitudinal assessment of cardiac toxicity in anthracycline\u2010treated long\u2010term bone tumor survivors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Procedures<\/jats:title><jats:p>Cardiac status was assessed in 29 patients 14.1 (range 7\u201318.7) years after treatment with doxorubicin (DOXO) 360 mg\/m<jats:sup>2<\/jats:sup> (median 225\u2013550). The median age of the patients at the time of the study was 32.5 years (range 19.7\u201352). The evaluation consisted of an electrocardiogram (ECG), 24\u2010hr ambulatory ECG with analysis of heart rate variability (HRV) and echocardiography. The results were compared to those of a study of the same patients that was performed 5 years earlier 8.9 years (range 2.3\u201314.1) after treatment. [Postma et al.: Med Pediatr Oncol 26:230\u2013237, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#bib4\">1996<\/jats:ext-link>]<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found no progression of ECG abnormalities, arrhythmias, or echocardiographic abnormalities. Females were at risk for reduced contractility (<jats:italic>P<\/jats:italic>\u2009=\u20090.006). HRV was significantly reduced compared to age\u2010 and sex\u2010matched controls and compared to the previous results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Anthracycline\u2010related late echocardiographic abnormalities and arrhythmias detected 8.9 years after treatment, showed no further deterioration with ongoing follow\u2010up. However, there was a significant reduction of HRV. This suggests that HRV might be a sensitive test for detection of anthracycline\u2010induced cardiac toxicity. Med Pediatr Oncol 2002;39:86\u201392. \u00a9 2002 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/mpo.10074","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T11:32:01Z","timestamp":1033903921000},"page":"86-92","source":"Crossref","is-referenced-by-count":22,"title":["Cardiac status in bone tumor survivors up to nearly 19 years after treatment with doxorubicin: A longitudinal study"],"prefix":"10.1002","volume":"39","author":[{"given":"A.","family":"Postma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.J.","family":"Elzenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Haaksma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.M.","family":"Schasfoort\u2010Van Leeuwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.A.","family":"Kamps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Th.E.","family":"Bink\u2010Boelkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,6,20]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03470120074036"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199103213241205"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506293322602"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199604)26:4<230::AID-MPO2>3.0.CO;2-K"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197601)37:1<1::AID-CNCR2820370102>3.0.CO;2-3"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)91393-I"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.10.1906"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(81)90611-6"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(77)80094-5"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.44.1.130"},{"key":"e_1_2_1_13_2","volume-title":"Heart rate variability in cardiology. Methodological and clinical aspects. Thesis","author":"Haaksma J","year":"1999"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","article-title":"Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation and clinical use","volume":"93","author":"Anonymous","year":"1996","journal-title":"Circulation"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00554-8"},{"key":"e_1_2_1_16_2","first-page":"97","volume-title":"Anthracycline cardiotoxicity in children: An echocardiographic study","author":"Daniels O","year":"1991"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(84)80397-6"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(94)90503-7"},{"key":"e_1_2_1_19_2","first-page":"807","volume-title":"Heart disease. A textbook of cardiovascular medicine","author":"Kaplan NM","year":"1997"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199602000-00014"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)91678-Q"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950210704"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.4.1544"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00685796"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.8.1321"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(84)80026-8"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809243391307"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950240604"},{"key":"e_1_2_1_29_2","first-page":"145A","article-title":"Ventricular tachycardia and sudden unexplained death in late survivors of childhood malignancy treated with doxorubicin","volume":"27","author":"Lipshultz SE","year":"1990","journal-title":"Pediatr Res"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(88)91172-1"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.15.1510"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00265-9"},{"key":"e_1_2_1_33_2","first-page":"449","volume-title":"Heart rate variability","author":"Casolo GC","year":"2001"},{"key":"e_1_2_1_34_2","first-page":"635","article-title":"Cardiac autonomic dysfunction in survivors of acute lymphoblastic leukemia in childhood","volume":"12","author":"Kamath MV","year":"1998","journal-title":"Int J Oncol"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-911X(200007)35:1<13::AID-MPO3>3.0.CO;2-G"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(94)00357-B"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.81.4.419"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(91)90602-6"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199808)31:2<73::AID-MPO5>3.0.CO;2-W"},{"key":"e_1_2_1_40_2","first-page":"659","article-title":"Afterload reduction therapy in long term survivors of childhood cancer treated with doxorubicin","volume":"84","author":"Lipshultz SE","year":"1991","journal-title":"Circulation"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90482-G"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90098-L"}],"container-title":["Medical and Pediatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmpo.10074","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mpo.10074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T13:03:42Z","timestamp":1700399022000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mpo.10074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,20]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["10.1002\/mpo.10074"],"URL":"https:\/\/doi.org\/10.1002\/mpo.10074","archive":["Portico"],"relation":{},"ISSN":["0098-1532","1096-911X"],"issn-type":[{"value":"0098-1532","type":"print"},{"value":"1096-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6,20]]}}}